Disclaimer: This is a simplified summary of a public company filing. See full disclaimer here.

DSwiss Inc

CIK: 16525612 Annual ReportsLatest: 2025-03-31

10-K / March 31, 2025

Revenue:$3,112,887
Income:$22,223

10-K / March 29, 2024

Revenue:$1,470,071
Income:-$49,535

10-K / March 31, 2025

Summary of DSwiss, Inc.

Business Overview

  • Core Activities: DSwiss, Inc. is a biotech nutraceutical firm specializing in the development, manufacturing, and supply of high-quality health and beauty products.
  • Product Range:
    • Functional foods and health supplements (nutraceuticals)
    • Skincare products (serums, creams, toners, masks, etc.)
    • Personal care and pet wellness products (pet shampoos and pet supplements)
    • Traditional medicines and natural products based on holistic and herbal remedies
    • Medical and diagnostic devices, notably the Quantum Resonant Magnetic Analyzer for health assessments

Business Operations

  • Primary Focus:
    • Providing turnkey private label OEM/ODM manufacturing solutions for health and beauty brands.
    • Custom formulation research and development.
    • Manufacturing, packaging, and distribution.
  • Standards & Certifications:
    • Complies with Malaysian MOH regulations.
    • GMP, HACCP, ISO, and MESTI standards.
    • Certifies products for JAKIM Halal.
  • Research & Development:
    • Pioneers evidence-based, natural formulations.
    • Manages R&D to develop new product lines and improve existing offerings.
  • Market Presence:
    • Significant growth in Malaysia, Singapore, Indonesia, Hong Kong, Australia, Taiwan, Macau, and China.
    • Active efforts to expand into global markets including the U.S., China, and Southeast Asian countries.
  • Distribution Channels:
    • Operates mainly online via its website (http://www.dswissbeauty.com/).
    • Uses social media platforms like Facebook, Instagram, and WeChat for marketing and customer engagement.
    • Plans to increase marketing efforts, including participation in international trade shows like HNC Shanghai and Vitafoods Asia.

Customer Base & Revenue

  • Number of Customers: The company’s revenue for 2024 was generated from OEM/ODM sales to multiple clients; exact number of individual customers is not provided.
  • Revenue (2024): $3,112,887 (an increase of 111.8% from 2023).
  • Income:
    • Net profit in 2024: $22,223 (a significant turnaround from a net loss of $49,535 in 2023).
    • Gross profit for 2024: $623,271, with a gross margin of approximately 20.02%.

Employees

  • As of December 31, 2024:
    • Total employees: 13 full-time employees.
    • Key personnel:
      • Vincent Leong (CEO, President, Secretary, Treasurer) who dedicates up to 70 hours a week.
      • Additional staff include R&D professionals, operations, and sales personnel to support growth and marketing initiatives.

Financial Overview (2024)

  • Total Revenue: $3,112,887
  • Gross Profit: $623,271
  • Net Income: $22,223
  • Assets: $635,830
    • Cash & equivalents: $397,476
    • Inventory: $3,350
    • Plant & equipment: $136,767
  • Liabilities: $561,794
  • Shareholders’ Equity: $74,036

Key Highlights

  • Focus on developing high-quality, natural, and scientifically validated health and beauty products.
  • Engages in turnkey OEM/ODM services supporting private label brands.
  • Continues research into innovative formulations and eco-friendly packaging.
  • Actively expanding global reach through strategic partnerships and market diversification.
  • Maintains ISO, GMP, HACCP, and halal certifications to meet strict regulatory standards.